Stock screener

INCY

Conviction 92HealthcareScan · Thu, Jun 25, 2026
INCY$107.54-0.85%
ResistanceSupportVol 14Insider sellCongress buyCongress sell
63 bars
Vol MA14 2.6M
Mar 26Apr 14May 1May 19Jun 8Jun 25
INCYTE CORPSERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCHwww.incyte.com ↗
Price107.54
Change-0.85%
Gap-1.10%
Rel volume2.77×
Avg volume2.41M
Avg $ vol246.02M
SMA 20101.61
SMA 5098.92
SMA 20097.19
Price vs 50+8.71%
Price vs 200+10.64%
MA stackbullish
50/200 cross—
Supertrendup · 96.78
RSI (14)61
MACD hist0.46
MACD crossbull · 2d
Stoch %K / %D78 / 77
ADX (14)17
+DI / −DI34 / 19
RSI divergence—
MACD divergence—
ATR %+3.60%
ADR %3.84%
52w high110.57
52w low67.27
From 52w high-2.74%
Above 52w low+59.86%
New 52w highNo
SqueezeOff
Bollinger width17.58%
%B0.83
Donchian pos82.71%
Donchian high110.75
Donchian low92.18
AVWAP (52w high)99.73
vs AVWAP high+7.83%
AVWAP (52w low)94.11
vs AVWAP low+14.26%
OBV trendFlat
Chaikin MF (20)-0.10
Today vs 20d2.77×
Avg vol (14d)2.6M
Avg vol (20d)2.41M
Avg $ vol (20d)246.02M
Market cap21.48B
RS 3m (vs SPY)+7.43%
RS 6m (vs SPY)-2.12%
RS line new highYes
Trend template7/8
Technical rank74.6
1 week+8.63%
1 month+10.75%
3 months+16.59%
6 months+6.78%
1 year+55.83%
YTD+6.03%
P/E16.70
P/B3.82
P/S4.18
P/FCF15.74
EPS6.41
Div yield—
ROE22.88%
ROA17.53%
Debt/Eq0.18
Current3.68
EV/EBITDA11.83
Gross margin—
Net margin25.03%
Rev growth21.22%
EPS growth3844.96%
Price target112.39
Target upside4.51%
Analyst ratingHold
Institutional113.62%
Ent. value19.03B
Revenue1.27B
Net income303.33M
Gross profit—
Free cash flow1.36B
IndustrySERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
ExchangeNasdaq
Shares out199.78M
Employees2.84K
ListedWed, Nov 3, 1993
Free float166.24M
Float %83.5%
Short interest11.4M
Days to cover9.2d
Short volume39.5%
Squeeze score54 / 100
Next earningsTue, Aug 4, 2026 (40d)
EPS forecast$1.56 · 8 est
Last EPS vs est$1.55 vs $1.14
Last surprise+36.0% beat
Setup gradeA+
Conviction92 / 100
Pattern quality—
Tech rank74.6 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance108.36
Support93.14
Days since event—
Candle confirm—
News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in INCY · 1 recent

All disclosures →
MemberSideAmount
Rob Bresnahan
Rob Bresnahan
house · PA · traded 2025-05-15
Sell$1K–$15K

Insider activity

SEC Form 4 transactions in INCY · 9 buys

InsiderSideShares
BAKER FELIX
Director · Non-Qualified Stock Options (right to buy) · 2026-06-08
Grant6.11K
BIENAIME JEAN JACQUES
Director · Non Qualfied Stock Option (right to buy) · 2026-06-08
Grant6.11K
BAKER JULIAN
Director · Non-Qualified Stock Options (right to buy) · 2026-06-08
Grant6.11K
BAKER BROS. ADVISORS LP
Director · Common Stock · 2026-06-08
Grant1.64K
BRAWLEY OTIS W
Director · Non Qualfied Stock Option (right to buy) · 2026-06-08
Grant6.11K
BIENAIME JEAN JACQUES
Director · Common Stock · 2026-06-08
Grant1.64K
BAKER JULIAN
Director · Common Stock · 2026-06-08
Other—
HARRIGAN EDMUND
Director · Non Qualfied Stock Option (right to buy) · 2026-06-08
Grant6.11K
Clancy Paul J
Director · Non Qualfied Stock Option (right to buy) · 2026-06-08
Grant6.11K
BAKER BROS. ADVISORS LP
Director · Non-Qualified Stock Options (right to buy) · 2026-06-08
Grant6.11K

SEC filings

EDGAR filings in INCY · 4 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.